DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 98 filers reported holding DESIGN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,086,523 | -62.5% | 460,391 | 0.0% | 0.03% | -58.0% |
| Q2 2023 | $2,900,463 | +9.2% | 460,391 | 0.0% | 0.07% | +9.5% |
| Q1 2023 | $2,656,456 | -43.8% | 460,391 | 0.0% | 0.06% | -44.7% |
| Q4 2022 | $4,723,612 | -38.6% | 460,391 | 0.0% | 0.11% | -42.7% |
| Q3 2022 | $7,698,000 | +19.4% | 460,391 | 0.0% | 0.20% | +5.9% |
| Q2 2022 | $6,445,000 | +15.5% | 460,391 | +33.2% | 0.19% | +34.3% |
| Q1 2022 | $5,581,000 | -22.2% | 345,597 | +3.1% | 0.14% | -15.7% |
| Q4 2021 | $7,178,000 | +46.3% | 335,247 | +0.4% | 0.17% | +61.2% |
| Q3 2021 | $4,907,000 | -25.7% | 334,050 | +0.6% | 0.10% | -21.4% |
| Q2 2021 | $6,604,000 | -32.5% | 332,050 | +1.5% | 0.13% | -38.5% |
| Q1 2021 | $9,785,000 | – | 327,250 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 5,364,850 | $78,810,000 | 3.20% |
| Logos Global Management LP | 2,772,501 | $40,728,000 | 2.94% |
| EcoR1 Capital, LLC | 1,863,098 | $27,369,000 | 0.95% |
| RA Capital Management | 2,186,636 | $32,122,000 | 0.44% |
| Vivo Capital, LLC | 530,991 | $7,800,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,468,318 | $21,570,000 | 0.34% |
| Artal Group S.A. | 400,000 | $5,876,000 | 0.13% |
| Rock Springs Capital Management LP | 334,050 | $4,907,000 | 0.10% |
| Baker Brothers Advisors | 1,436,636 | $21,104,000 | 0.09% |
| Eventide Asset Management | 400,000 | $5,876,000 | 0.08% |